HALO logo
halo search icon
Olema Pharmaceuticals, Inc.

US$14.06

Price Change Indicator
0.10 (0.716%)
Olema Pharmaceuticals, Inc.
OLMA · NAS

Olema Pharmaceuticals, Inc.

Start Trading OLMA for Free

US$14.06

Price Arrow0.10 (0.716%)
21/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusEMA 125 BreakdownHALO AllHALO Consensus ValueHALO MomentumNear Support
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Olema Pharmaceuticals, Inc. Overview

OLMA Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Strong

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Strong

About OLMA

icon
icon

Telephone

1.415.651.3316

icon

Address

780 Brannan Street, San Francisco, CA 94103

Description

Olema Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of next generation targeted therapies for women’s cancers. Its product candidate, OP-1250, is a novel oral therapy with combined activity as both a complete ER antagonist, or CERAN, and a selective ER degrader, or SERD, which is believed to drive deeper, more durable responses than existing therapies. The company was founded by Cyrus L. Harmon and Peter J. Kushner on August 7, 2006 and is headquartered in San Francisco, CA.

OLMA Price Chart

Key Stats

Market Cap

US$1.22B

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 3.89 - 36.26

Trade Value (12mth)

US$8,109,303.00

1 week

2.72%

1 month

-14.04%

YTD

-44.78%

1 year

170.54%

All time high

60.27

Key Fundamentals

EPS 3 yr Growth

-28.70%

EBITDA Margin

0.00%

Operating Cashflow

-$147m

Free Cash Flow Return

-32.90%

ROIC

-36.50%

Interest Coverage

0.00

Quick Ratio

10.00

Other Data

Shares Outstanding (Fully Diluted)

103m

HALO Sector

Healthcare

Next Company Report Date

23-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

OLMA Announcements

Latest Announcements

DateAnnouncements
22 May 26
22 May 26
12 May 26
12 May 26
12 May 26

OLMA Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-2.14-2.2-1.87locklocklock
EPS (Fully Diluted)
 $locklocklocklock-2.14-2.2-1.87locklocklock
Growth
 %locklocklocklock18.5-3.215.3locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Olema Pharmaceuticals, Inc. (OLMA:NAS)?
Halo FAQ
The current share price of Olema Pharmaceuticals, Inc. (OLMA:NAS) is USD$14.06.
What is the 52-week high share price for Olema Pharmaceuticals, Inc. (OLMA:NAS)?
Halo FAQ
The 52-week high share price for Olema Pharmaceuticals, Inc. (OLMA:NAS) is USD$36.26.
What is the 52-week low share price for Olema Pharmaceuticals, Inc. (OLMA:NAS)?
Halo FAQ
The 52-week low share price for Olema Pharmaceuticals, Inc. (OLMA:NAS) is USD$3.89.
What is the dividend yield for Olema Pharmaceuticals, Inc. (OLMA:NAS)?
Halo FAQ
Olema Pharmaceuticals, Inc. (OLMA:NAS) does not pay a dividend.
What was Olema Pharmaceuticals, Inc. (OLMA:NAS) last dividend payment?
Halo FAQ
Olema Pharmaceuticals, Inc. (OLMA:NAS) does not pay a dividend.
What is the franking level for Olema Pharmaceuticals, Inc. (OLMA:NAS)?
Halo FAQ
Olema Pharmaceuticals, Inc. (OLMA:NAS) has a franking level of 0.00%.
In which sector is Olema Pharmaceuticals, Inc. (OLMA:NAS) classified?
Halo FAQ
Olema Pharmaceuticals, Inc. (OLMA:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial